Research progress on naltrexone in the treatment of children with inflammatory bowel disease / 中国小儿急救医学
Chinese Pediatric Emergency Medicine
;
(12): 71-74, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-930808
ABSTRACT
Inflammatory bowel disease refers to a group of non-specific chronic gastrointestinal inflammatory diseases of unknown causes, including ulcerative colitis, Crohn′s disease and indeterminate colitis.Recently, the incidence of inflammatory bowel disease in children has increased, which seriously affects the growth and development of children and the quality of life.Studies have shown that the opioid receptor antagonist naltrexone can reverse the inflammatory activity in inflammatory bowel disease and promote cell repair.This review summarized the research of application of naltrexone in the treatment of inflammatory bowel disease, aiming to further explore the effectiveness and safety of naltrexone in the treatment of inflammatory bowel disease in children.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Pediatric Emergency Medicine
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS